These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 37279904)

  • 1. Recent progress in CRISPR-based bioengineering of microbial cell factories for important nutraceuticals synthesis.
    Hussain MI; Raziq A; Ahmed A; Iqbal MW; Tian R; Li J; Liu L; Liu Y
    J Appl Microbiol; 2023 Jun; 134(6):. PubMed ID: 37279904
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolic engineering of microbial cell factories for production of nutraceuticals.
    Yuan SF; Alper HS
    Microb Cell Fact; 2019 Mar; 18(1):46. PubMed ID: 30857533
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Engineering microbial cell factories for the production of plant natural products: from design principles to industrial-scale production.
    Liu X; Ding W; Jiang H
    Microb Cell Fact; 2017 Jul; 16(1):125. PubMed ID: 28724386
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Applications of CRISPR in a Microbial Cell Factory: From Genome Reconstruction to Metabolic Network Reprogramming.
    Wu Y; Liu Y; Lv X; Li J; Du G; Liu L
    ACS Synth Biol; 2020 Sep; 9(9):2228-2238. PubMed ID: 32794766
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of GRAS strains for nutraceutical production using systems and synthetic biology approaches: advances and prospects.
    Liu L; Guan N; Li J; Shin HD; Du G; Chen J
    Crit Rev Biotechnol; 2017 Mar; 37(2):139-150. PubMed ID: 26699901
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Research progress of engineering microbial cell factories for pigment production.
    Xu S; Gao S; An Y
    Biotechnol Adv; 2023; 65():108150. PubMed ID: 37044266
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Engineering microbial factories for synthesis of value-added products.
    Du J; Shao Z; Zhao H
    J Ind Microbiol Biotechnol; 2011 Aug; 38(8):873-90. PubMed ID: 21526386
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CRISPR-based bioengineering in microalgae for production of industrially important biomolecules.
    Dhokane D; Shaikh A; Yadav A; Giri N; Bandyopadhyay A; Dasgupta S; Bhadra B
    Front Bioeng Biotechnol; 2023; 11():1267826. PubMed ID: 37965048
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Engineered CRISPR Systems for Next Generation Gene Therapies.
    Pineda M; Moghadam F; Ebrahimkhani MR; Kiani S
    ACS Synth Biol; 2017 Sep; 6(9):1614-1626. PubMed ID: 28558198
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CRISPR-Cas9/CRISPRi tools for cell factory construction in E. coli.
    Hashemi A
    World J Microbiol Biotechnol; 2020 Jun; 36(7):96. PubMed ID: 32583135
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CRISPR/Cas9 advances engineering of microbial cell factories.
    Jakočiūnas T; Jensen MK; Keasling JD
    Metab Eng; 2016 Mar; 34():44-59. PubMed ID: 26707540
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microbial production of value-added nutraceuticals.
    Wang J; Guleria S; Koffas MA; Yan Y
    Curr Opin Biotechnol; 2016 Feb; 37():97-104. PubMed ID: 26716360
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microbial physiological engineering increases the efficiency of microbial cell factories.
    Liu H; Qi Y; Zhou P; Ye C; Gao C; Chen X; Liu L
    Crit Rev Biotechnol; 2021 May; 41(3):339-354. PubMed ID: 33541146
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Critical Review of Genome Editing and Synthetic Biology Applications in Metabolic Engineering of Microalgae and Cyanobacteria.
    Ng IS; Keskin BB; Tan SI
    Biotechnol J; 2020 Aug; 15(8):e1900228. PubMed ID: 32080963
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent advancement of engineering microbial hosts for the biotechnological production of flavonoids.
    Shah FLA; Ramzi AB; Baharum SN; Noor NM; Goh HH; Leow TC; Oslan SN; Sabri S
    Mol Biol Rep; 2019 Dec; 46(6):6647-6659. PubMed ID: 31535322
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Road to the future of systems biotechnology: CRISPR-Cas-mediated metabolic engineering for recombinant protein production.
    Roointan A; Morowvat MH
    Biotechnol Genet Eng Rev; 2016; 32(1-2):74-91. PubMed ID: 28052722
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CRISPR/Cas genome editing to optimize pharmacologically active plant natural products.
    Dey A
    Pharmacol Res; 2021 Feb; 164():105359. PubMed ID: 33285226
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microbial production of nutraceuticals: Metabolic engineering interventions in phenolic compounds, poly unsaturated fatty acids and carotenoids synthesis.
    Madhavan A; Arun KB; Alex D; Anoopkumar AN; Emmanual S; Chaturvedi P; Varjani S; Tiwari A; Kumar V; Reshmy R; Awasthi MK; Binod P; Aneesh EM; Sindhu R
    J Food Sci Technol; 2023 Aug; 60(8):2092-2104. PubMed ID: 37273565
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent advances in tuning the expression and regulation of genes for constructing microbial cell factories.
    Jung SW; Yeom J; Park JS; Yoo SM
    Biotechnol Adv; 2021; 50():107767. PubMed ID: 33974979
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Engineering status of protein for improving microbial cell factories.
    Zhou P; Gao C; Song W; Wei W; Wu J; Liu L; Chen X
    Biotechnol Adv; 2024; 70():108282. PubMed ID: 37939975
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.